Literature DB >> 11292887

Antimicrobial management measures to limit resistance: A process-based conceptual framework.

S DeLisle 1, T M Perl .   

Abstract

To curb the trend toward increasingly resistant microorganisms, we must at least ensure that antibiotics are used in accordance with the best available scientific evidence. Here we review the control and streamlining measures aimed at optimizing the use of antibiotics, placing an emphasis on their demonstrated effectiveness in the intensive care unit environment. Because of their wide variety, the measures have been organized along the process of choosing, dosing, delivering, and then adjusting the initial antibiotics according to the culture results. By clarifying the range of options available, this process-based conceptual framework assists in best adapting a creative mixture of control measures to a particular healthcare system. The framework also facilitates the overview of a proposed multidisciplinary antibiotic management program, thereby helping to secure the administrative and local provider support necessary for its implementation and continued improvement.

Mesh:

Substances:

Year:  2001        PMID: 11292887     DOI: 10.1097/00003246-200104001-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Inaccurate communications in telephone calls to an antimicrobial stewardship program.

Authors:  Darren R Linkin; Sarah Paris; Neil O Fishman; Joshua P Metlay; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2006-06-22       Impact factor: 3.254

2.  Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial.

Authors:  Bernard C Camins; Mark D King; Jane B Wells; Heidi L Googe; Manish Patel; Ekaterina V Kourbatova; Henry M Blumberg
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

3.  A sustainable strategy to prevent misuse of antibiotics for acute respiratory infections.

Authors:  Gail B Rattinger; C Daniel Mullins; Ilene H Zuckerman; Eberechukwu Onukwugha; Loreen D Walker; Adi Gundlapalli; Matthew Samore; Sylvain Delisle
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.